The leptin era: New insight into the mechanisms of body weight homeostasis

Journal of Pediatric Gastroenterology and Nutrition

Volumn 29, Issue 3, 1999, Pages 250-264

  Hoppin, Alison G ^a,b   Kaplan, Lee M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN;

BODY WEIGHT; ENERGY METABOLISM; ENVIRONMENTAL FACTOR; GENETIC LINKAGE; HOMEOSTASIS; HUMAN; MOLECULAR CLONING; NUTRITIONAL DISORDER; OBESITY; PRIORITY JOURNAL; PUBLIC HEALTH; SHORT SURVEY;

ADOLESCENT; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; ENVIRONMENT; HOMEOSTASIS; HUMANS; INFANT; LEPTIN; MODELS, BIOLOGICAL; OBESITY; PROTEINS;

EID: 0033511868     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-199909000-00005     Document Type: Short Survey

References (163)

1. Kuczmarski RJ, Carroll MD, Flegal KM, Troiano RP. Varying body mass index cutoff points to describe overweight prevalence among U.S. adults. Obes Res 1997;5:542.
2. Rosner B, Prineas R, Loggie J, Daniels SR. Percentiles for body mass index in U.S. children 5 to 17 years of age. J Pediatr 1998;132:211-22.
3. Singh RB, Mori H, Chen J, et al. Recommendations for the prevention of coronary artery disease in Asians: a scientific statement of the International College of Nutrition. Cardiovasc Risk 1996;3:489-94.
4. Andersen LB, Henckel P, Saltin B. Risk factors for cardiovascular disease in 16-19-year-old teenagers. J Intern Med 1989;225: 157-63.
5. Maffeis C, Schutz Y, Piccoli R, Gonfiantini E, Pinelli L. Prevalence of obesity in children in north-east Italy. Int J Obes Relat Metab Disord 1993;17:287-94.
6. Pi-Sunyer FX. Medical hazards of obesity. Ann Intern Med 1993; 119:655-60.
7. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983;67:968-77.
8. Folsom AR, Jacobs DR, Jr., Wagenknecht LE, et al. Increase in fasting insulin and glucose over seven years with increasing weight and inactivity of young adults. The CARDIA Study. Coronary Artery Risk Development in Young Adults. Am J Epidemiol 1996;144:235-46.
9. Solomon CG, Manson JE. Obesity and mortality: a review of the epidemiologic data. Am J Clin Nutr 1997;66:1044S-50S.
10. Hoffmans MD, Kromhout D, Coulander CD. Body Mass Index at the age of 18 and its effects on 32-year-mortality from coronary heart disease and cancer. A nested case-control study among the entire 1932 Dutch male birth cohort. J Clin Epidemiol 1989;42: 513-20.
11. Wolf AM, G.A. C. Current estimates of the economic costs of obesity in the United States. Obes Res 1998;6:97-106.
12. McGinnis JM, Foege WH. Actual causes of death in the United States. JAMA 1993;270:2207-12.
13. Loder RT. The demographics of slipped capital femoral epiphysis. An international multicenter study. Clin Orthop 1996:8-27.
14. Scott IU, Siatkowski RM, Eneyni M, Brodsky MC, Lam BL. Idiopathic intracranial hypertension in children and adolescents. Am J Ophthalmol 1997;124:253-5.
15. Radhakrishnan K, Thacker AK, Bohlaga NH, Maloo JC, Gerryo SE. Epidemiology of idiopathic intracranial hypertension: a prospective and case-control study. J Neurol Sci 1993;116:18-28.
16. Lessell S. Pediatric pseudotumor cerebri (idiopathic intracranial hypertension). Surv Ophthalmol 1992;37:155-66.
17. Mallory GB, Jr., Fiser DH, Jackson R. Sleep-associated breathing disorders in morbidly obese children and adolescents. J Pediatr 1989;115:892-7.
18. Douglas NJ, Polo O. Pathogenesis of obstructive sleep apnoea/ hypopnoea syndrome. Lancet 1994;344:653-5.
19. Glaser NS. Non-insulin-dependent diabetes mellitus in childhood and adolescence. Pediatr Clin North Am 1997;44:307-37.
20. Kawasaki T, Hashimoto N, Kikuchi T, Takahashi H, Uchiyama M. The relationship between fatty liver and hyperinsulinemia in obese Japanese children. J Pediatr Gastroenterol Nutr 1997;24: 317-21.
21. Baldridge AD, Perez-Atayde AR, Graeme-Cook F, Higgins L, Lavine JE. Idiopathic steatohepatitis in childhood: a multicenter retrospective study. J Pediatr 1995;127:700-4.
22. Gortmaker SL, Must A, Perrin JM, Sobol AM, Dietz WH. Social and economic consequences of overweight in adolescence and young adulthood. N Engl J Med 1993;329:1008-12.
23. Kirschner BS. Ulcerative colitis and Crohn's disease in children. Diagnosis and management. Gastroenterol Clin North Am 1995; 24:99-117.
24. Borowitz D. The interrelationship of nutrition and pulmonary function in patients with cystic fibrosis. Curr Opin Pulm Med 1996;2:457-61.
25. Winter H, Chang TI. Gastrointestinal and nutritional problems in children with immunodeficiency and AIDS. Pediatr Clin North Am 1996;43:573-90.
26. Grinspoon S, Gulick T, Askari H, et al. Serum leptin levels in women with anorexia nervosa. J Clin Endocrinol Metab 1996; 81:3861-3.
27. Kirschner BS, Sutton MM. Somatomedin-C levels in growth-impaired children and adolescents with chronic inflammatory bowel disease. Gastroenterology 1986;91:830-6.
28. Nagy TR, Gower BA, Trowbridge CA, Dezenberg C, Shewchuk RM, Goran MI. Effects of gender, ethnicity, body composition, and fat distribution on serum leptin concentrations in children. J Clin Endocrinol Metab 1997;82:2148-52.
29. Rosenbaum M, Nicolson M, Hirsch J, et al. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab 1996;81:3424-7.
30. Woodward CJ. A re-evaluation of the anabolic effect of testosterone in rats: interactions with gonadectomy, adrenalectomy and hypophysectomy. Acta Endocrinol 1993;128:473-7.
31. Roy EJ, Wade GN. Role of food intake in estradiol-induced body weight changes in female rats. Horm Behav 1977;8:265-74.
32. Kramer FM, Jeffery RW, Forster JL, Snell MK. Long-term follow-up of behavioral treatment for obesity: patterns of weight regain among men and women. Int J Obes 1989;13:123-36.
33. Grodstein F, Levine R, Troy L, Spencer T, Colditz GA, Stampfer MJ. Three year follow-up of participants in a commercial weight loss program. Arch Intern Med 1996;156:1302-1306.
34. Weigle DS. Appetite and the regulation of body composition. FASEB J 1994;8:302-10.
35. Kennedy GC. The role of depot fat in the hypothalamic control of food intake in the rat. Proc R Soc London B Biol Sci 1953;140: 579.
36. Harris RB, Martin RJ. Specific depletion of body fat in parabiotic partners of tube-fed obese rats. Am J Physiol 1984;247:R380-6.
37. Hervey GR. The effects of lesions in the hypothalamus in parabiotic rats. J Physiol 1959;145:336-52.
38. Parameswaran SV, Steffens AB, Hervey GR, de Ruiter L. Involvement of a humoral factor in regulation of body weight in parabiotic rats. Am J Physiol 1977;232:R150-7.
39. Coleman DL. Effects of parabiosis of obese with diabetes and normal mice. Diabetologia 1973;9:294-8.
40. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-32.
41. Potter JJ, Womack L, Mezey E, Anania FA. Transdifferentiation of rat hepatic stellate cells results in leptin expression. Biochem Biophys Res Commun 1998;244:178-82.
42. Masuzaki H, Ogawa Y, Sagawa N, et al. Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat Med 1997;3:1029-33.
43. Bado A, Levasseur S, Attoub S, et al. The stomach is a source of leptin. Nature 1998;394:790-793.
44. Campfield L, Smith F, Guisez Y, Devos R, Burn P. Recombinant mouse ob protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995;269:546-549.
45. Halaas JL, Gajiwala KS, Maffei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269:543-6.
46. Pelleymounter MA, Cullen MJ, Baker MB, et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995;269:540-3.
47. Tartaglia LA, Dembski M, Weng X, et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995;83: 1263-71.
48. Lee GH, Proenca R, Montez JM, et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996;379:632-5.
49. Friedman JM. Leptin, leptin receptors and the control of body weight. Eur J Med Res 1997;2:7-13.
50. Kieffer TJ, Heller RS, Habener JF. Leptin receptors express on pancreatic beta-cells. Biochem Biophys Res Commun 1996;224: 522-7.
51. Golden PL, Maccagnan TJ, Pardridge WM. Human blood-brain barrier leptin receptor. Binding and endocytosis in isolated human brain microvessels. J Clin Invest 1997;99:14-8.
52. Lollmann B, Gruninger S, Stricker-Krongrad A, Chiesi M. Detection and quantification of the leptin receptor splice variants Ob-Ra, b, and, e in different mouse tissues. Biochem Biophys Res Commun 1997;238:648-52.
53. Bjorbaek C, Uotani S, da Silva B, Flier JS. Divergent signaling capacities of the long and short isoforms of the leptin receptor. J Biol Chem 1997;272:32686-95.
54. Ghilardi N, Ziegler S, Wiestner A, Stoffel R, Heim MH, Skoda RC. Defective STAT signaling by the leptin receptor in diabetic mice. Proc Natl Acad Sci U S A 1996;93:6231-5.
55. Sinha MK, Opentanova I, Ohannesian JP, et al. Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting. J Clin Invest 1996;98: 1277-82.
56. Liu C, Liu XJ, Barry G, Ling N, Maki RA, De Souza EB. Expression and characterization of a putative high affinity human soluble leptin receptor. Endocrinology 1997;138:3548-54.
57. Li C, Ioffe E, Fidahusein N, Connolly E, Friedman JM. Absence of soluble leptin receptor in plasma from dbPas/dbPas and other db/db mice. J Biol Chem 1998;273:10078-82.
58. Lee G, Li C, Montez J, Halaas J, Darvishzadeh J, Friedman JM. Leptin receptor mutations in 129 db3J/db3J mice and NIH facp/ facp rats. Mamm Genome 1997;8:445-7.
59. Chua SC, Jr., Chung WK, Wu-Peng XS, et al. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 1996;271:994-6.
60. Ahima RS, Prabakaran D, Mantzoros C, et al. Role of leptin in the neuroendocrine response to fasting. Nature 1996;382:250-2.
61. Hardie LJ, Guilhot N, Trayhurn P. Regulation of leptin production in cultured mature white adipocytes. Horm Metab Res 1996; 28:685-9.
62. De Vos P, Saladin R, Auwerx J, Staels B. Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake. J Biol Chem 1995;270:15958-61.
63. Papaspyrou-Rao S, Schneider SH, Petersen RN, Fried SK. Dexamethasone increases leptin expression in humans in vivo. J Clin Endocrinol Metab 1997;82:1635-7.
64. Grunfeld C, Zhao C, Fuller J, et al. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J Clin Invest 1996;97:2152-7.
65. Kirchgessner TG, Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Tumor necrosis factor-alpha contribute to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Invest 1997;100:2777-82.
66. Cusin I, Sainsbury A, Doyle P, Rohner-Jeanrenaud F, Jeanrenaud B. the ob gene and insulin. A relationship leading to clues to the understanding of obesity. Diabetes 1995;44:1467-70.
67. Saad MF, Khan A, Sharma A, et al. Physiological insulinemia acutely modulates plasma leptin. Diabetes 1998;47:544-9.
68. Rentsch J, Chiesi M. Regulation of ob gene mRNA levels in cultured adipocytes. FEBS Lett 19986;379:55-9.
69. Kamohara S, Burcelin R, Halaas JL, Friedman JM, Charron MJ. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 1997;389:374-7.
70. Sivitz WI, Walsh SA, Morgan DA, Thomas MJ, Haynes WG. Effects of leptin on insulin sensitivity in normal rats. Endocrinology 1997;138:3395-401.
71. Cohen B, Novick D, Rubinstein M. Modulation of insulin activities by leptin. Science 1996;274:1185-8.
72. Muller G, Ertl J, Gerl M, Preibisch G. Leptin impairs metabolic actions of insulin in isolated rat adipocytes. J Biol Chem 1997; 272:10585-93.
73. Barash IA, Cheung CC, Weigle DS, et al. Leptin is metabolic signal to the reproductive system. Endocrinology 1996;137: 3144-7.
74. Ahima RS, Dushay J, Flier SN, Prabakaran D, Flier JS. Leptin accelerates the onset of puberty in normal female mice. J Clin Invest 1997;99:391-5.
75. Carro E, Senaris R, Considine RV, Casanueva FF, Dieguez C. Regulation of in vivo growth hormone secretion by leptin. Endocrinology 1997;138:2203-6.
76. Pas mouse. J Nutr 1987;115:327-333.
77. Clement K, Vaisse C, Lahlou N, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998;392:398-401.
78. Cioffi JA, Shafer AW, Zupancic TJ, et al. Novel B2219/OB receptor isoforms: possible role of leptin in hematopoiesis and reproduction. Nat Med 1996;2:585-9.
79. Loffreda S, Yang SQ, Lin HZ, et al. Leptin regulates proinflammatory immune responses. FASEB J 1998;12:57-65.
80. Flier JS, Maratos-Flier E. Obesity and the hypothalamus: novel peptides for new pathways. Cell 1998;92:437-40.
81. Woods SC, Seeley RJ, Porte D, Jr., Schwartz MW. Signals that regulate food intake and energy homeostasis. Science 1998;280: 1378-83.
82. Tomaszuk A, Simpson C, Williams G, Neuropeptide Y, the hypothalamus and the regulation of energy homeostasis. Horm Res 1996;46:53-8.
83. Stephens TW, Basinski M, Bristow PK, et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 19995;377:530-2.
84. Green PK, Wilkinson CW, Woods SC. Intraventricular corticosterone increases the rate of body weight gain in underweight adrenalectomized rats. Endocrinology 1992;130:269-75.
85. Cusin I, Dryden S, Wang Q. Rohner-Jeanrenaud F, Jeanrenaud B, Williams G. Effect of sustained physiological hyperinsulinaemia on hypothalamic neuropeptide Y and NPY mRNA levels in the rat. J Neuroendocrinol 1995;7:193-7.
86. Erickson JC, Hollopeter G, Palmiter RD. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 1996;274:1704-7.
87. Sakurai T, Amemiya A, Ishii M, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998;92: 573-85.
88. Qu D, Ludwig DS, Gammeltoft S, et al. A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature 1996;380:243-7.
89. Yamamoto Y, Ueta Y, Date Y, et al. Down regulation of the prepro-orexin gene expression in genetically obese mice. Brain Res Mol Brain Res 1999;65:14-22.
90. Erickson JC, Clegg KE, Palmiter RD. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 1996;381:415-21.
91. Shimada M, Tritos NA, Lowell BB, Flier JS, Maratos-Flier E. Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature 1998;396:670-4.
92. Schioth HB, Muceniece R, Larsson M, Wikberg JE. The melancortin 1, 3, 4 or 5 receptors do not have a binding epitope for ACTH beyond the sequence of alpha-MSH. J Endocrinol 1997; 155:73-8.
93. Schwartz MW, Seeley RJ, Woods SC, et al. Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 1997;46:2119-23.
94. Thornton JE, Cheung CC, Clifton DK, Steiner RA. Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. Endocrinology 1997;138:5063-6.
95. Huszar D, Lynch CA, Fairchild-Huntress V, et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997;88:131-41.
96. Cone RD, Lu D, Koppula S, et al. The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation. Recent Prog Horm Res 1996;98:1101-6.
97. Barrachina MD, Martinez V, Wang L, Wei JY, Tache Y. Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice. Proc Natl Acad Sci U S A 1997;94:10455-60.
98. Matson CA, Wiater MF, Kuijper JL, Weigle DS. Synergy between leptin and cholecystokinin (CCK) to control daily caloric intake. Peptides 1997;18:1275-8.
99. Nagle DL, McGrail SH, Vitale J, et al. The mahogany protein is a receptor involved in suppression of obesity. Nature 1999;398: 148-152.
100. Gunn TM, Miller KA, He L, et al. The mouse mahogany locus encodes a transmembrane form of human attractin. Nature 1999; 398:152-156.
101. Bray GA. Obesity, a disorder of nutrient partitioning: the MONA LISA hypothesis. J Nutr 1991;121:1146-62.
102. Bray GA, York DA. Clinical review 90: Leptin and clinical medicine: a new piece in the puzzle of obesity. J Clin Endocrinol Metab 1997;82:2771-6.
103. Cunningham S, Leslie P, Hopwood D, et al. The characterization and energetic potential of brown adipose tissue in man. Clin Sci (Colch) 1985;69:343-8.
104. Boss O, Samec S, Paoloni-Giacobino A, et al. Uncoupling protein-3: a new member of the mitochondrial carrier family with tissue-specific expression. FEBS Lett 1997;408:39-42.
105. Fleury C, Neverova M, Collins S, et al. Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet 1997;15:269-72.
106. Solanes G, Vidal-Puig A, Grujic D, Flier JS, Lowell BB. The human uncoupling protein-3 gene. Genomic structure, chromosomal localization, and genetic basis for short and long form transcripts. J Biol Chem 1997;272:25433-6.
107. Cusin I, Zakrezewska KE, Boss O, et al. Chronic central leptin infusion enhances insulin-stimulated glucose metabolism and favors the expression of uncoupling proteins. Diabetes 1998;47: 1014-9.
108. Scarpace PJ, Matheny M, Pollock BH, Turner N. Leptin increases uncoupling protein expression and energy expenditure. Am J Physiol 1997;273:E226-30.
109. Qian H, Azain MJ, Compton MM, Hartzell DL, Hausman GJ, Baile CA. Brain administration of leptin causes deletion of adipocytes by apoptosis. Endocrinology 1998;139:791-4.
110. Zhou TY, Shimabukuro M, Koyama K, et al. Induction by leptin of uncoupling protein-2 and enzymes of fatty acid oxidation. Proc Natl Acad Sci U S A 1997;94:6386-90.
111. Kolaczynski JW, Nyce MR, Considine RV, et al. Acute and chronic effect of insulin on leptin production in humans - studies in vivo and in vitro. Diabetes 1996;45:699-701.
112. Pagano C, Englaro P, Granzotto M, et al. Insulin induces rapid changes of plasma leptin in lean but not in genetically obese (fa/fa) rats. Int J Obes Relat Metab Disord 1997;21:614-8.
113. Kulkarni RN, Wang ZL, Wang RM, et al. Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. J Clin Invest 1997;100:2729-36.
114. Seufert J, Kieffer TJ, Leech CA, et al. Leptin suppression of insulin secretion and gene expression in human pancreatic islets: implications for the development of adipogenic diabetes mellitus. J Clin Endocrinol Metab 1999;84:670-6.
115. Uysal KT, Wiesbrock SM, Marino MW, Hotasmisligil GS. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997;389:610-4.
116. Montague CT, Farooqi IS, Whitehead JP, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997;387:903-8.
117. Strobel A, Issad T, Camoin L, Ozata M, Strosberg AD. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet 1998;18:213-5.
118. Considine RV, Considine EL, Williams CJ, et al. Mutation screening and identification of a sequence variation in the human ob gene coding region. Biochem Biophys Res Commun 1996;220: 735-9.
119. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-5.
120. Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte D, Jr. Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat Med 1996;2:589-93.
121. Cummings DE, Brandon EP, Planas JV, Motamed K, Idzerda RL, McKnight GS. Genetically lean mice result from targeted disruption of the RII beta subunit of protein kinase A Nature 1996;382: 622-6.
122. Comuzzie AG, Blangero J, Mahaney MC, et al. Major gene with sex-specific effects influences fat mass in Mexican Americans. Genet Epidemiol 1995;12:475-88.
123. Borecki IB, Bonney GE, Rice T, Bouchard C, Rao DC. Influence of genotype-dependent effects of covariates on the outcome of segregation analysis of the body mass index. Am J Hum Genet 1993;53:676-87.
124. Comuzzie AG, Allison DB. The search for human obesity genes. Science 1998;280:1374-7.
125. Bray G, Bouchard C. Genetics of human obesity: research directions. FASEB J 1997;11:937-45.
126. Bouchard C, Perusse L. Current status of the human obesity gene map. Obes Res 1996;4:81-90.
127. Bouchard C. Genetics of human obesity: recent results from linkage studies. J Nutr 1997;127:1887S-1890S.
128. Duggirala R, Stern MP, Mitchell BD, et al. Quantitative variation in obesity-related traits and insulin precursors linked to the OB gene region on human chromosome 7. Am J Hum Genet 1996; 59:694-703.
129. Bouchard C, Perusse L, Chagnon YC, Warden C, Ricquier D. Linkage between markers in the vicinity of the uncoupling protein 2 gene and resting metabolic rate in humans. Hum Mol Genet 1997;6:1887-9.
130. Ristow M, Muller-Wieland D, Pfeiffer A, Krone W, Kahn CR. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. N Engl J Med 1998;339.
131. Gu W, Tu Z, Kleyn PW, et al. Identification and functional analysis of novel human melanocortin-4 receptor variants. Diabetes 1999;48:635-9.
132. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 1998;19:155-7.
133. Chagnon YC, Perusse L, Bouchard C. The human obesity gene map: the 1997 update. Obes Res 1998;6:76-92.
134. Mitchell BD, Blangero J, Comuzzie AG, et al. A paired sibling analysis of the beta-3 adrenergic receptor and obesity in Mexican Americans. J Clin Invest 1998;101:584-7.
135. Widen E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Groop LC. Association of a polymorphism in the beta 3-adrenergic-receptor gene with feature of the insulin resistance syndrome in Finns. N Engl J Med 1995;333:348-51.
136. Mauriege P, Bouchard C. Trp64Arg mutation in beta 3-adrenoceptor gene of doubtful significance for obesity and insulin resistance. Lancet 1996;348:698-9.
137. Gagnon J, Mauriege P, Roy S, et al. The Trp64Arg mutation of the beta3 adrenergic receptor gene has no effect on obesity phenotypes in the Quebec Family Study and Swedish Obese Subjects cohorts. J Clin Invest 1996;98:2086-93.
138. Moriarty M, Wing RR, Kuller LH, Ferrell RE. Trp64Arg substitution in the beta 3-adrenergic receptor does not relate to body weight in healthy, premenopausal women. Int J Obes Relat Metab Disord 1997;21:826-9.
139. Normal RA, Thompson DB, Fouroud T, et al. Genomewide search for genes influence percent body fat in Pima Indians: suggestive linkage at chromosome 11q21-q22. Pima Diabetes Gene Group. Am J Hum Genet 1997;60:166-73.
140. Price RA, Charles MA, Pettitt DJ, Knowler WC. Obesity in Pima Indians: large increases among post-World War Il birth cohorts. Am J Phys Anthropol 1993;92:473-9.
141. Epstein LH. Exercise in the treatment of childhood obesity. Int J Obes 1995;19:S117-121.
142. Service AR. Data tables:results from USDA's 1995 continuing survey of food intakes by individuals and 1995 diet and health knowledge survey. Riverdale, Maryland: Department of Agriculture, Food Surveys Research Group, 1995.
143. Power C, Lake JK, Cole TJ. Measurement and long-term health risks of child and adolescent fatness. Int J Obes Relat Metab Disord 1997;21:507-26.
144. Panel NIoHE. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Washington D.C.: National Institutes of Health, National Heart, Lung, and Blood Institute, 1998.
145. Himes JH, Dietz WH. Guidelines for overweight in adolescent preventive services: recommendations from an expert committee. The Expert Committee On Clinical Guidelines for Overweight in Adolescent Preventive Services. Am J Clin Nutr 1994;59:307-16.
146. Pietrobelli A, Faith MS, Allison DB, Gallagher D, Chiumello G, Heymsfield SB. Body mass index as a measure of adiposity among children and adolescents: a validation study. J Pediatr 1998;132:204-10.
147. Dietz WH, Robinson TN. Use of the body mass index (BMI) as a measure of overweight in children and adolescents. J Pediatr 1998;132:191-3.
148. Epstein LH, Valoski A, Wing RR, McCurley J. Ten-year follow-up of behavioral, family-based treatment for obese children. JAMA 1990;264:2519-23.
149. Figueroa-Colon R, von Almen TK, Franklin FA, Schuftan C, Suskind RM. Comparison of two hypocaloric diets in obese children. Am J Dis Child 1993;147:160-6.
150. Figueroa-Colon R, Franklin FA, Lee JY, von Almen TK, Suskind RM. Feasibility of a clinic-based hypocaloric dietary intervention implemented in a school setting for obese children. Obes Res 1996;4:419-29.
151. Capella JF, Capella RF. The weight reduction operation of choice: vertical banded gastroplasty or gastric bypass? Am J Surg 1996;171:74-9.
152. Hocking MP, Duerson MC, O'Leary JP, Woodward ER. Jejunoileal bypass for morbid obesity. Late follow-up in 100 cases. N Engl J Med 1983;308:995-9.
153. Hoppin AG, Kaplan LM, Zurakowski D, Leichtner AM, Bousvaros A, Serum leptin in children and young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nittr 1998;26: 500-5.
154. Heimburger O, Lonnqvist F, Danielsson A, Nordenstrom J, Stenvinnkel P. Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure. J Am Soc Nephrol 1997;8:1423-30.
155. Yong GA, Woodrow G, Kendall S, et al. Increased plasma leptin/fat ratio in patients with chronic renal failure: a cause of malnutrition? Nephrol Dial Transplant 1997;12:2318-23.
156. Sarraf P, Frederich RC, Turner EM, et al. Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J Exp Med 1997;185:171-5.
157. Stratton RJ, Dewit O, Crowe E, Jennings G, Villar RN, Elia M. Plasma leptin, energy intake and hunger following total hip replacement surgery. Clin Sci (Colch) 1997;93:113-7.
158. Friedman JM, Leibel RL. Tackling a weighty problem. Cell 1992; 69:217-220.
159. Collin GB, Marshall JD, Cardon LR, Nishina PM. Homozygosity mapping at Alstrom syndrome to chromosome 2p. Hum Mol Genet 1997;6:213-9.
160. Beales PL, Warner AM, Hitman GA, Thakker R, Flinter FA. Bardet-Biedl syndrome: a molecular and phenotypic study of 18 families. J Med Genet 1997;34:92-8.
161. Gunay-Aygaun M, Cassidy SB, Nicholls RD. Prader-Willi and other syndromes associated with obesity and mental retardation. Behav Genet 1997;27:307-24.
162. Kolehmainen J, Norio R, Kivite-Kallio S, Tahvanainen E, de la Chapelle A, Lehesjoki AE. Refined mapping of the Cohen syndrome gene by linkage disequilibrium, Eur J Hum Genet 1997; 5:206-13.
163. Whitaker RC, Wright JA, Pepe MS, Seidel KD, Dietz WH. Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med 1997;337:869-73.